Factors Affecting the Weaning from Nasal CPAP in Preterm Neonates

Table 4

Multivariate analysis for PMA at successful NCPAP weaning and significant predictor variables, analysis done for the group as a whole and when stratified by intubation.

	Full cohort (𝑛=454)			Nonintubated (𝑛=326)			Intubated (𝑛=128)
	Beta	95% CI	𝑃value	Beta	95% CI	𝑃value	Beta	95% CI	𝑃value
BW	−0.90	−1.50–0.28	0.004	−0.76	−0.17–1.30	0.01	−2.50	−4.02–0.99	0.001
Gender	−0.14	−0.54–0.26	0.5	−0.15	−0.51–0.20	0.39	−0.13	−1.10–0.85	0.8
Chorioamnionitis	1.14	0.19–2.10	<0.01	0.72	0.16–1.60	0.01	0.95	−1.18–3.08	0.38
Sepsis/NEC	0.67	−0.05–1.38	0.06	0.71	−0.03–1.50	0.06	0.21	−1.12–1.54	0.75
Anemia	1.05	0.56–1.55	<.0001	0.91	0.50–1.30	<.001	0.61	−2.10–3.40	0.69
IVH	1.14	0.57–1.72	<.01	0.52	−0.13–1.18	0.1	0.80	−0.20–1.82	0.12
GE reflux	1.99	1.16–2.82	<.0001	1.44	0.23–2.65	.02	1.23	−0.06–2.52	0.06

Abbreviations: BW: birth weight, IVH: intraventricular hemmorhage, NEC: necrotizing enterocolitis, GE Reflux: gastroesophageal reflux.